ONXEO (EPA:ALONX) | Finanzwire

Basculer en Français

9535	Companies
187704	Keywords
119664	Articles
100297	Press releases

Home
Companies
ONXEO

PRESS RELEASE

published on 10/30/2025 at 09:05, 1 month 17 days ago

Half-Year Financial Report 2025
BRIEF

published on 10/30/2025 at 09:03, 1 month 17 days ago

Valerio Therapeutics' financial and strategic review for the first half of 2025

Strategic Refocusing Valerio Therapeutics 2025 Financial Results V-Body Platforms Seeking Partnerships
PRESS RELEASE

published on 10/30/2025 at 09:00, 1 month 17 days ago

Press Release Publication Half-Year Financial Report 2025
Valerio Therapeutics S.A. announces first-half 2025 financial results, discontinuation of clinical activities, and strategic refocus on preclinical R&D. Strengthened financial structure through shareholder advances and capital increases

Financial Results Valerio Therapeutics First-half 2025 Preclinical R&D Shareholder Advances
BRIEF

published on 03/19/2025 at 15:32, 8 months 27 days ago

Valerio Therapeutics Announces Board Members and Their Roles

Board Members Valerio Therapeutics Corporate Roles Paris-based Company Executive Responsibilities
PRESS RELEASE

published on 03/19/2025 at 15:27, 8 months 27 days ago

Inside Information / Other news releases
Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025

Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF

published on 03/19/2025 at 12:35, 8 months 28 days ago

Valerio Therapeutics Board Meeting Decisions

Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments
PRESS RELEASE

published on 03/19/2025 at 12:30, 8 months 28 days ago

Inside Information / Other news releases
Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers

Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
BRIEF

published on 02/04/2025 at 10:40, 10 months 12 days ago

Valerio Therapeutics opts for strategic refocusing

Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
PRESS RELEASE

published on 02/04/2025 at 10:35, 10 months 12 days ago

Inside Information / Other news releases
Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development

Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
BRIEF

published on 10/01/2024 at 00:56, 1 year 2 months ago

Valerio Therapeutics Reports First Half 2024 Financial Results

Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies

Accesswire

Published on 12/16/2025 at 13:00, 16 minutes ago

Abasca Resources Provides Exploration Update at its Loki Flake Graphite Deposit and Granting Stock Option
Published on 12/16/2025 at 13:00, 16 minutes ago

Silver Wolf Completes Acquisition of the Ana Maria Project
Published on 12/16/2025 at 12:00, 1 hour 16 minutes ago

Tokenwell Plans to Establish U.S. Subsidiary in Dallas, Texas, to Expand its Presence in the Growing Digital Asset Hub
Published on 12/16/2025 at 12:00, 1 hour 16 minutes ago

CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
Published on 12/16/2025 at 12:00, 1 hour 16 minutes ago

Snowline Gold Awards Key Contracts and Commences Prefeasibility Study on its Flagship Rogue Project, Yukon

View all ACCESSWIRE

EQS Group

Published on 12/16/2025 at 12:55, 21 minutes ago

Banyan Group's Garrya Mu Cang Chai Opens in a National Heritage Site in Northern Vietnam
Published on 12/16/2025 at 12:22, 54 minutes ago

REPLOID Group AG: HEROSAN launches crowdfunding campaign
Published on 12/16/2025 at 12:05, 1 hour 11 minutes ago

BRP Announces Appointment of Denis Le Vot as President and Chief Executive Officer
Published on 12/16/2025 at 12:00, 1 hour 16 minutes ago

DATAGROUP initiates delisting procedure on the Munich Stock Exchange
Published on 12/16/2025 at 11:49, 1 hour 27 minutes ago

Strategic Investment: CANSOUL acquires stake in SYNBIOTIC

Les Echos

Published on 12/16/2025 at 08:30, 4 hours 46 minutes ago

Cie du Bois Sauvage: Buy back of own shares – week from 08/12/2025 to 12/12/2025
Published on 12/15/2025 at 22:36, 14 hours 40 minutes ago

Disclosure of trading in own shares between December 1st and December 5th, 2025
Published on 12/15/2025 at 18:30, 18 hours 46 minutes ago

MCH PRIVATE EQUITY AND EURAZEO ENTER INTO AN EXCLUSIVE AGREEMENT WITH ARDIAN FOR THE SALE OF THEIR MAJORITY STAKE IN FERMAX
Published on 12/15/2025 at 18:05, 19 hours 11 minutes ago

Covivio - Treasury shares transactions between December 8th , 2025 and December 12th, 2025
Published on 12/15/2025 at 17:45, 19 hours 31 minutes ago

ENGIE strengthens the resilience of the Belgian electricity system with new flexible capacities

View all LES ECHOS COMFI WIRE